[Federal Register Volume 71, Number 79 (Tuesday, April 25, 2006)]
[Notices]
[Page 23926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-3872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM) 
meeting.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 
5 U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: June 8, 2006.
    Closed: 9 a.m. to 12 p.m.
    Agenda: Deliberation on grant applications.
    Open: 1 p.m. to 3:30 p.m.
    Agenda: Presentations on current and proposed research.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31C, 6th Flr., Conference Room 10, Bethesda, MD 20892.
    Contact Person: Martin H. Goldrosen, PhD., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892. (301) 594-2014.
    This public comments session is scheduled from 3-3:30 p.m. but 
could change depending on the actual time spent on each agenda item. 
Each speaker will be permitted 5 minutes for their presentation. 
Interested individuals and representatives or organizations are 
requested to notify Dr. Martin H. Goldrosen, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-594-2014, Fax: 
301-480-9970. Letters of intent to present comments, along with a 
brief description of the organization represented, should be 
received no later than 5 p.m. on May 29, 2006. Anyone representative 
of an organization may present oral comments. Any person attending 
the meeting who does not request an opportunity to speak in advance 
of the meeting may be considered for oral presentation, if time 
permits, and at the discretion of the Chairperson. In addition, 
written comments may be submitted to Dr. Martin H. Goldrosen at the 
address listed above up to ten calendar days (June 18, 2006) 
following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by contacting Dr. Martin H. Goldrosen, 
Executive Secretary, NACCAM, National Center for Complementary and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax 
301-480-9970, or via e-mail at [email protected].
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by nongovernment 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.

    Dated: April 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-3872 Filed 4-24-06; 8:45 am]
BILLING CODE 4140-01-M